Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347
Want to see HK:3347 full AI Analyst Report?
Total Valuation
Hangzhou Tigermed Consulting Co., Ltd. Class H has a market cap or net worth of HK$35.73B. The enterprise value is HK$29.22B.
Market CapHK$35.73B
Enterprise ValueHK$29.22B
Share Statistics
Hangzhou Tigermed Consulting Co., Ltd. Class H has 123,124,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding123,124,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hangzhou Tigermed Consulting Co., Ltd. Class H’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.11%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.11%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee613.91K
Profits Per Employee72.33K
Employee Count11,130
Asset Turnover0.24
Inventory Turnover119.50
Valuation Ratios
The current PE Ratio of Hangzhou Tigermed Consulting Co., Ltd. Class H is 48.7. Hangzhou Tigermed Consulting Co., Ltd. Class H’s PEG ratio is 0.31.
PE Ratio48.7
PS Ratio4.81
PB Ratio1.57
Price to Fair Value1.57
Price to FCF36.40
Price to Operating Cash Flow25.65
PEG Ratio0.31
Income Statement
In the last 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H had revenue of 6.83B and earned 887.89M in profits. Earnings per share was 1.03.
Revenue6.83B
Gross Profit1.87B
Operating Income1.01B
Pretax Income1.00B
Net Income887.89M
EBITDA1.42B
Earnings Per Share (EPS)1.03
Cash Flow
In the last 12 months, operating cash flow was 1.39B and capital expenditures -217.95M, giving a free cash flow of 1.17B billion.
Operating Cash Flow1.39B
Free Cash Flow1.17B
Free Cash Flow per Share9.50
Dividends & Yields
Hangzhou Tigermed Consulting Co., Ltd. Class H pays an annual dividend of HK$0.145, resulting in a dividend yield of 0.8%
Dividend Per ShareHK$0.145
Dividend Yield0.8%
Payout Ratio41.18%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.86
52-Week Price Change-11.09%
50-Day Moving Average35.92
200-Day Moving Average42.62
Relative Strength Index (RSI)52.33
Average Volume (3m)2.64M
Important Dates
Hangzhou Tigermed Consulting Co., Ltd. Class H upcoming earnings date is Aug 20, 2026, TBA (Not Confirmed).
Last Earnings DateApr 28, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
Hangzhou Tigermed Consulting Co., Ltd. Class H as a current ratio of 2.18, with Debt / Equity ratio of 8.26%
Current Ratio2.18
Quick Ratio2.16
Debt to Market Cap0.03
Net Debt to EBITDA-0.21
Interest Coverage Ratio11.15
Taxes
In the past 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H has paid 198.16M in taxes.
Income Tax198.16M
Effective Tax Rate0.20
Enterprise Valuation
Hangzhou Tigermed Consulting Co., Ltd. Class H EV to EBITDA ratio is 22.95, with an EV/FCF ratio of 36.07.
EV to Sales4.77
EV to EBITDA22.95
EV to Free Cash Flow36.07
EV to Operating Cash Flow29.15
Balance Sheet
Hangzhou Tigermed Consulting Co., Ltd. Class H has HK$2.20B in cash and marketable securities with HK$1.53B in debt, giving a net cash position of HK$670.88M billion.
Cash & Marketable SecuritiesHK$2.20B
Total DebtHK$1.53B
Net CashHK$670.88M
Net Cash Per ShareHK$5.45
Tangible Book Value Per ShareHK$23.76
Margins
Gross margin is 26.64%, with operating margin of 14.77%, and net profit margin of 12.99%.
Gross Margin26.64%
Operating Margin14.77%
Pretax Margin14.68%
Net Profit Margin12.99%
EBITDA Margin20.79%
EBIT Margin16.01%
Analyst Forecast
The average price target for Hangzhou Tigermed Consulting Co., Ltd. Class H is HK$54.07, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$54.07
Price Target Upside0.13% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast10.65%
EPS Growth Forecast134.38%